| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |